how big is the glp-1 market Agonists Weight Loss Drugs Report, 2025-2030 GLP-1 Market Size, Share |

The spray will dry in approximately 30 seconds

This decline is connected to a lower risk for heart disease and diabetes

With the advent of branded drugs like Ozempic and Mounjaro, clinicians now have tools that not only lower blood glucose but also promote substantial weight loss and cardiovascular benefits

This clean profile means you get the growth hormone boost without the unwanted hormonal side effects

One participant stated: "While on Mounjaro, I couldn't smoke, but after stopping it for about a month, I went back to smoking." (Male, 8 months on GLP-1 therapy) "During the period of use, the need for nicotine noticeably decreased, but after the treatment period ended, the desire to smoke gradually increased." (Male, 6 months on GLP-1 therapy) In contrast, a subset of participants reported no observable perceived impact of GLP-1 on their smoking behavior

Participants received a GLP-1 between 2015 and 2025 and had MS clinic visits within 1 year before and at least 1 month after treatment initiation